CHO HANNA,BREMER RYAN,SPEVAK WAYNE,ZHANG JIAZHONG,IBRAHIM PRABHA N
申请号：
NZ59986610
公开号：
NZ599866A
申请日:
2010.11.04
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
Pyrrolo[2,3-b]pyridinyl compounds of formula II&rsquo； and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are disclosed, wherein the variables are as defined in the specification. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, or forms thereof are active on Fms protein kinase, or on Fms and Kit protein kinase, or on Fms and Flt-3 protein kinase. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of Fms protein kinase, Kit protein kinase, or Flt-3 protein kinase including rheumatoid arthiritis, osteoarthritis, multiple sclerosis, Alzheimer&rsquo；s disease, Parkinson&rsquo；s disease, glomerulonephritis, interstitial nephritis, Lupus nephritis, tubular necrosis, diabetic nephropathy, renal hypertrophy, acute myeloid leukemia, melanoma, multiple myeloma, metastatic breast cancer, prostate cancer, pancreatic cancer, neurofibromatosis, brain metastases, and gastrointestinal stromal tumors. In one embodiment the compound is [6-Fluoro-5-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-(6-methoxy-pyridin-3-ylmethyl)-amine.
